Cerclage pessary containing progesterone of prolonged, sustained, and continuous release useful for prevention of preterm birth
Cerclage pessary containing progesterone homogeneously distributed in the pessary body providing a prolonged, sustained and continuous release for a period of at least 6 months, wherein the pessary consists of dimethylsiloxane elastomer with RTV (Room Temperature Vulcanization) mechanism, the progesterone amount is from 20% to 30% w/w, relative to pessary weight and the ratios of the polymers forming the matrix is from 6:1 to 14 1. The cerclage pessary is useful for the prevention of preterm birth. Progesterone diffuses through the polymer continuously, without altering the shape and integrity of the pessary, since the elastomer forming the polymeric matrix used herein is not biodegradable. This guarantees that the form of pessary remains intact until the end of treatment.
1. A cervical pessary consisting of 20% to 30% w/w of progesterone homogenously distributed throughout 70% to 80% w/w of a dimethylsiloxane elastomer,
wherein the dimethylsiloxane elastomer consists of:
(A) a polydimethylsiloxane-vinyl polymer containing amorphous silica, and
(B) a copolymer of dimethyl methylhydrogensiloxane and polydimethylsiloxane; having an A:B ratio ranging from 6:1 to 14:1,
wherein the cervical pessary has a prolonged, sustained and continuous release of progesterone for a period of at least 6 months, and maintains its intact form all the time.
2. A cervical pessary according to claim 1 , wherein the amount of progesterone in the pessary is from 5.0 g to 10.5 g.
3. A cervical pessary according to claim 1 , having a weight between 25 and 35 grams.
4. A cervical pessary according to claim 1 , wherein the amount of progesterone sustained and continuously released from the pessary is of 15 mg to 65 mg daily, for a period of at least 6 months.
5. A cervical pessary according to claim 1 , wherein the A:B ratio is 6:1, 8:1, 10:1, 12:1 or 14:1.
6. A method for preventing preterm birth comprising administering the cervical pessary according to claim 1 to a patient in need thereof.
7. A cervical pessary according to claim 1 , wherein:
the polydimethylsiloxane-vinyl polymer (A) contains amorphous silica in an amount of 25% w/w of the polymer (A), and
the copolymer (B) is a copolymer of 20% dimethyl methylhydrogensiloxane with polydimethylsiloxane.
8. A cervical pessary according to claim 7 , wherein the amount of progesterone in the pessary is from 5.0 g to 10.5 g.
9. A cervical pessary according to claim 7 , having a weight between 25 and 35 grams.
10. A cervical pessary according to claim 7 , wherein the amount of progesterone initially released from the pessary is of 15 mg to 65 mg daily, for a period of at least 6 months.
11. A cervical pessary according to claim 7 , wherein the A:B ratio is 6:1, 8:1, 10:1, 12:1 or 14:1.
12. A method for preventing preterm birth comprising administering the cervical pessary according to claim 7 to a patient in need thereof.